- Home
- SOHO vs CING Comparison
SOHO vs CING Comparison
Compare SOHO & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHO
- CING
- Stock Information
- Founded
- SOHO 2004
- CING 2012
- Country
- SOHO United States
- CING United States
- Employees
- SOHO N/A
- CING N/A
- Industry
- SOHO Real Estate Investment Trusts
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- SOHO Real Estate
- CING Health Care
- Exchange
- SOHO Nasdaq
- CING Nasdaq
- Market Cap
- SOHO 18.0M
- CING 17.3M
- IPO Year
- SOHO 2004
- CING 2021
- Fundamental
- Price
- SOHO $0.89
- CING $5.16
- Analyst Decision
- SOHO Hold
- CING Strong Buy
- Analyst Count
- SOHO 1
- CING 4
- Target Price
- SOHO $1.50
- CING $30.67
- AVG Volume (30 Days)
- SOHO 21.6K
- CING 112.4K
- Earning Date
- SOHO 08-12-2025
- CING 08-12-2025
- Dividend Yield
- SOHO N/A
- CING N/A
- EPS Growth
- SOHO N/A
- CING N/A
- EPS
- SOHO N/A
- CING N/A
- Revenue
- SOHO $182,158,199.00
- CING N/A
- Revenue This Year
- SOHO $13.93
- CING N/A
- Revenue Next Year
- SOHO N/A
- CING N/A
- P/E Ratio
- SOHO N/A
- CING N/A
- Revenue Growth
- SOHO 3.11
- CING N/A
- 52 Week Low
- SOHO $0.59
- CING $1.80
- 52 Week High
- SOHO $1.54
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- SOHO 50.13
- CING 57.48
- Support Level
- SOHO $0.84
- CING $4.25
- Resistance Level
- SOHO $0.96
- CING $5.60
- Average True Range (ATR)
- SOHO 0.05
- CING 0.37
- MACD
- SOHO -0.00
- CING 0.03
- Stochastic Oscillator
- SOHO 41.67
- CING 51.70
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.